New Prostate Cancer Blood Test Could Reduce Biopsies

A new blood test that looks for circulating tumor cells could significantly improve the diagnosis of prostate cancer and avoid unnecessary biopsies and treatments. Combining the new test with prostate specific antigen (PSA) results can yield a diagnosis of aggressive prostate cancer that is more than 90% accurate, according to a Journal of Urology study.

Read the full article here.

Source: Catharine Paddock - Medical News Today